NCT06691607View on ClinicalTrials.gov

NGAL in Prediction of AKI and Patient Outcomes

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

March 1, 2022

Study Completion Date

June 1, 2022

Conditions
To Determine If Blood Level (NGAL) Could Accurately Early Detect Acute Renal Damage in All Patients Requiring Critical Care
Interventions
OTHER

Serum NGAL level

serum NGAL level

Trial Locations (1)

Unknown

Sohag University, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT06691607 - NGAL in Prediction of AKI and Patient Outcomes | Biotech Hunter | Biotech Hunter